LON:CVSG

CVS Group (CVSG) Share Price, News & Analysis

GBX 979
+21.00 (+2.19%)
(As of 04/30/2024 ET)
Today's Range
955
984.10
50-Day Range
920.33
1,688
52-Week Range
902.41
2,226
Volume
131,436 shs
Average Volume
226,982 shs
Market Capitalization
£701.65 million
P/E Ratio
1,958.00
Dividend Yield
0.82%
Price Target
GBX 2,135

CVS Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
118.1% Upside
GBX 2,135 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-1.52mentions of CVS Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.85 out of 5 stars

CVSG stock logo

About CVS Group Stock (LON:CVSG)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste disposal services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.

CVSG Stock Price History

CVSG Stock News Headlines

NYSE Spotlight & A Soaring Biotech Breakthrough You Need to See
The CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything.
CVS Group (LON:CVSG) Sets New 12-Month Low at $905.00
CVS Health: Seizing Opportunity Amid Recent Declines
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
CVS Group Share Chat
CVS Group PLC CVSG
CVS Group plc (CVSG.L)
CVS Group PLC
CVS to close more of its doors around the District
See More Headlines
Receive CVSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/29/2017
Today
4/30/2024

Industry, Sector and Symbol

Industry
Personal Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
9,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 2,135
High Stock Price Target
GBX 2,370
Low Stock Price Target
GBX 1,900
Potential Upside/Downside
+119.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
£35.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£641.90 million
Cash Flow
GBX 32.12 per share
Book Value
GBX 372 per share

Miscellaneous

Free Float
N/A
Market Cap
£698.22 million
Optionable
Not Optionable
Beta
0.95
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Richard William Mark Fairman F.C.A. (Age 57)
    CEO & Director
    Comp: $895k
  • Mr. Robin Jay Alfonso F.C.A. (Age 45)
    CFO & Director
    Comp: $571k
  • Mr. Benjamin David Jacklin DipECVS (Age 40)
    M.A., MRCVS, MVetMed, VetMB, Deputy CEO & Director
    Comp: $651k
  • Charlotte Page
    Group Financial Controller & Head of Investor Relations
  • Mr. Scott Morrison
    Group General Counsel & Legal Secretary
  • Ms. Helen Finney
    Group HR Director
  • Mr. Gordon Palmer
    Head of IT
  • Mr. Paul Higgs
    Chief Veterinary Officer
  • James Cahill
    MVB - Managing Director of CVS International
  • Mr. Robert Dawson
    Small Animal Director

CVSG Stock Analysis - Frequently Asked Questions

Should I buy or sell CVS Group stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CVS Group in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CVSG shares.
View CVSG analyst ratings
or view top-rated stocks.

What is CVS Group's stock price target for 2024?

2 brokerages have issued 1 year price objectives for CVS Group's shares. Their CVSG share price targets range from GBX 1,900 to GBX 2,370. On average, they anticipate the company's stock price to reach GBX 2,135 in the next year. This suggests a possible upside of 118.1% from the stock's current price.
View analysts price targets for CVSG
or view top-rated stocks among Wall Street analysts.

How have CVSG shares performed in 2024?

CVS Group's stock was trading at GBX 1,683 on January 1st, 2024. Since then, CVSG shares have decreased by 41.8% and is now trading at GBX 979.
View the best growth stocks for 2024 here
.

How were CVS Group's earnings last quarter?

CVS Group plc (LON:CVSG) issued its earnings results on Friday, September, 29th. The company reported $42.80 earnings per share for the quarter, beating the consensus estimate of $42.30 by $0.50. The company earned $271.80 million during the quarter. CVS Group had a trailing twelve-month return on equity of 14.19% and a net margin of 5.51%.

How often does CVS Group pay dividends? What is the dividend yield for CVS Group?

CVS Group declared a dividend on Thursday, September 21st. Shareholders of record on Thursday, November 2nd will be paid a dividend of GBX 7.50 per share on Friday, December 8th. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, November 2nd. This is an increase from the stock's previous dividend of GBX 7. The official announcement can be accessed at this link.
Read our dividend analysis for CVSG
.

Is CVS Group a good dividend stock?

CVS Group (LON:CVSG) pays an annual dividend of GBX 8 per share and currently has a dividend yield of 0.80%. The dividend payout ratio is 1,600.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CVSG.

What other stocks do shareholders of CVS Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Group investors own include AbbVie (ABBV), Advanced Micro Devices (AMD), CVS Health (CVS), Burford Capital (BUR), Diageo (DEO), Walt Disney (DIS), Intel (INTC), Marvell Technology (MRVL), Micron Technology (MU) and NVIDIA (NVDA).

How do I buy shares of CVS Group?

Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CVSG) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners